Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019)
Relmada Therapeutics' (RLMD) quarterly Debt Ratio came in at 0.0 in Q4 2019, down 97.29% year-on-year from 0.03 in Q4 2018, and down 96.87% on a QoQ basis from 0.03 in Q3 2019.
Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019) Analysis & Trends
Relmada Therapeutics (RLMD) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q4 2019.
- On a quarterly basis, Debt Ratio fell 97.29% year-over-year to 0.0 in Q4 2019; TTM through Dec 2019 was 0.0, a 97.29% decrease from a year earlier, with the FY2019 full-year figure at 0.0, changed N/A from the prior year.
- Debt Ratio for Q4 2019 stood at 0.0, down from 0.03 in the prior quarter.
- Over the last five years, Debt Ratio for RLMD reached as high as 2.05 in Q3 2018 and fell as low as 0.0 in Q4 2019.
- Historically, Debt Ratio has averaged 0.15 across 5 years, with a median of 0.02 in 2016.
- Across the five-year window, Debt Ratio jumped 1596.81% in 2018 and slumped 98.54% in 2019, its largest moves.
- Year by year, Debt Ratio stood at 0.01 in 2015, then jumped by 231.52% to 0.02 in 2016, then surged by 999.98% to 0.19 in 2017, then plunged by 82.11% to 0.03 in 2018, then tumbled by 97.29% to 0.0 in 2019.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q4 2019, 0.03 in Q3 2019, and 0.04 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 0.03 |
| Jun 30, 2019 | 0.04 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.03 |
| Sep 30, 2018 | 2.05 |
| Jun 30, 2018 | 0.09 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2017 | 0.12 |
| Jun 30, 2017 | 0.10 |
| Mar 31, 2017 | 0.01 |
| Dec 31, 2016 | 0.02 |
| Sep 30, 2016 | 0.02 |
| Jun 30, 2016 | 0.03 |
| Dec 31, 2015 | 0.01 |
| Sep 30, 2015 | 0.01 |
| Jun 30, 2015 | 0.01 |
| Jun 30, 2014 | 0.00 |